In this study, we report a highly efficient transgenesis technique for Xenopus tropicalis based on a method described first for Medaka. This simple procedure entails co-injection of meganuclease I-SceI and a transgene construct flanked by two I-SceI sites into fertilized eggs. Approximately 30% of injected embryos express transgenes in a promoter-dependent manner. About 1/3 of such embryos show incorporation of the transgene at the one-cell stage and the remainder are 'half-transgenics' suggesting incorporation at the two-cell stage. Transgenes from both classes of embryos are shown to be transmitted and expressed in offspring. The procedure also works efficiently in Xenopus laevis. Because the needle injection procedure does not significantly damage embryos, a high fraction develop normally and can, as well, be injected with a second reagent, for example an mRNA or antisense morpholino oligonucleotide, thus allowing one to perform several genetic manipulations on embryos at one time. This simple and efficient technique will be a powerful tool for high-throughput transgenesis assays in founder animals, and for facilitating genetic studies in the fast-breeding diploid frog, X. tropicalis. q
Introduction
Xenopus has been widely used in studies of developmental biology, because of the ease with which one can perform embryological manipulations and inject molecules (e.g. mRNAs) into embryos. In addition, the transgenesis technique by restriction endonuclease mediated integration (REMI) that was developed about 10 years ago provided a powerful new tool for the Xenopus system, because it was more efficient than transgenic procedures in other vertebrates (Kroll and Amaya, 1996; Amaya and Kroll, 1999) . In this method, decondensed sperm nuclei are incubated with a linearized transgene construct, restriction enzyme, and Xenopus egg extract, and subsequently transplanted into unfertilized eggs. After the transplantation the transgene is immediately integrated into the partially digested host genome. Hence, the transgene shows non-mosaic, correct spatio-temporal expression pattern in founder transgenic animals.
The REMI method was originally developed in Xenopus laevis, the most favored species in the Xenopus genus for developmental biology studies. The REMI method made it possible to manipulate the Xenopus genome, including procedures which could be used for insertional mutagenesis (Bronchain et al., 1999) . However, because of its pseudotetraploid genome and long generation time (1-2 years under normal conditions (Duellman and Trueb, 1986) ), genetic studies in X. laevis remain problematic.
To overcome this drawback, we have been involved in the development of X. tropicalis, a close relative of X. laevis, as a new experimental system for developmental genetics (Amaya et al., 1998; Offield et al., 2000; Hirsch et al., 2002a) . X. tropicalis is the only diploid species in the genus (de Sa and Hillis, 1990 ) with a genome size nearly half that of mouse (1.7!10 9 bp/haploid nucleus (Tymowska, 1973) ), and a significantly shorter generation time (3-5 months) than X. laevis. Their adult size is approximately one quarter that of X. laevis, allowing more animals to be housed in equivalent space for multi-generation experiments. Their embryos are smaller than those of X. laevis (0.7-0.8 versus 1.0-1.3 mm, respectively), but are sufficiently large for embryological manipulations and injection of molecules like mRNA. The REMI method was also adapted to X. tropicalis (Offield et al., 2000) , Mechanisms of Development 123 (2006) and further modified to improve the transgenesis efficiency (Hirsch et al., 2002b) . Up to now, however, transgenic X. tropicalis have not been as widely generated by many researchers as one might expect. The major reason is the challenges associated with the Xenopus REMI transgenesis procedure. The sperm nuclear transplantation, which uses a relatively large needle, is a burden on the recipient eggs, so its success strongly depends on egg quality. In X. laevis, the rate of transplanted eggs that develop normally to tadpoles fluctuates between 1 and 16% (20-40% of transplanted eggs cleave normally, and 5-40% of the cleaving eggs develop normally subsequently; (Kroll and Amaya, 1996) ). In addition, some experience in the sperm nuclear transplantation is required to increase the transgenesis efficiency to a satisfactory level, and preparation of Xenopus egg or oocyte extract, which are used in the X. laevis and X. tropicalis transgenesis procedures (Hirsch et al., 2002b) , is somewhat laborious. A simplified REMI method for X. laevis, which does not require the egg extract (Sparrow et al., 2000) , was tried in X. tropicalis, but was not successful (J. Gray and R. M. Grainger, unpublished).
Recently, a novel transgenesis method in the fish Medaka (Oryzias latipes), which is quite different from the REMI method, was reported (Thermes et al., 2002) . This method uses a meganuclease, I-SceI, an intron-encoded homing endonuclease isolated from the yeast Saccharomyces cerevisiae (Jacquier and Dujon, 1985) . A reporter gene flanked by two I-SceI recognition sites was co-injected together with I-SceI into fertilized eggs, where the enzyme stimulated promoterdependent expression of the reporter. The reporter expression in founder fish still included some mosaic expression, but the transgenes were transmitted to the offspring at high frequency. The mechanisms underlying this transgenesis technique are not clear. One speculation is that continued binding of I-SceI to the digested ends of injected transgenes prevents concatemer formation and/or degradation of linear monomers, which generally inhibits integration of transgenes into the host genome (Thermes et al., 2002) . The great advantage of this method is its simplicity; it is performed by standard microinjection with a fine needle and requires neither the laborious sperm nuclear transplantation nor fish-specific materials.
In this study we successfully adapted the I-SceI-mediated transgenesis method to X. tropicalis by modifying the original fish method. The fraction of embryos exhibiting non-mosaic promoter dependent expression of the reporter construct reached more than 30% of injected embryos at optimized conditions, which is much higher than that achieved by the REMI method in X. tropicalis (2-5% (Hirsch et al., 2002b) ). The transgenes expressed in founder embryos showed germline transmission and appropriate expression in offspring.
The method we report here will be a standard tool not only for reporter assays or misexpression experiments in transgenic founder animals but also for multi-generation experiments in Xenopus, such as enhancer or gene trap screening. In addition, the injection procedure is compatible with injection of other molecules into embryos, e.g. mRNAs or morpholino antisense oligonucleotides, for studies of gene interactions.
Results

Uniform promoter-dependent expression of a transgene co-injected with I-SceI meganuclease
To test the potential of I-SceI meganuclease-mediated transgenesis in X. tropicalis, we made a reporter plasmid carrying a Pax6 promoter-GFP cassette flanked by two I-SceI recognition sites at both ends (IS-Pax6GFP, Fig. 1A ). The promoter used in this study is the K3.6 kb region of the Xenopus Pax6 gene, whose activity was already well characterized by REMI transgenesis in X. laevis (Hartley et al., 2001) .
As in the original report of the I-SceI transgenesis in fish (Thermes et al., 2002) , the reporter plasmid was incubated with I-SceI enzyme in I-SceI buffer, and subsequently the enzyme reaction mixture containing the digested plasmid DNA was injected into each X. tropicalis embryo at the one-cell stage (see Section 4 for details; all stages according to Nieuwkoop and Faber, 1967) . We initially chose to inject 40 pg of DNA to avoid possible toxic effects, because the volume of one X. tropicalis egg is approximately one third of that of X. laevis whose maximum capacity for simple DNA injection is generally thought to be about 100 pg (Sive et al., 2000) . After the injection, GFP expression in the embryos was examined at different developmental stages using an epifluorescent microscope until they reached tadpole stages (through st. 41).
Of 150 injected embryos, 126 developed normally, and four of them (3% of total injected embryos, Table 1 ) exhibited uniform tissue-specific expression, which was first detected at around stage 20 in the developing eyes (Fig. 1B) . Subsequently, the expression became visible in the developing brain and spinal cord at the tailbud (Fig. 1C ) and tadpole stages (Fig. 1D ). The GFP expression was further examined by in situ hybridization for higher sensitivity and resolution, which revealed weak ectopic expression in several ventral cells (arrowhead in Fig. 1E ) but confirmed the non-mosaic expression in other tissues (arrows in Fig. 1E ). The spatiotemporal expression pattern of GFP observed here is essentially identical with that in the transgenic embryos generated by the REMI method using the same Pax6 promoter-GFP cassette ( Fig. 1H ; (Hartley et al., 2001) ). Besides these putative 'full' transgenic embryos, 13 embryos (9%) had the uniform promoter-dependent expression only one side of the body ( Fig. 1F,G ; Table 1 ). These embryos are likely to be 'half transgenics', which are sometimes seen as well with the REMI transgenesis method (Hartley et al., 2001 ). The transgene integration likely occurred at the two-cell stage in these embryos. In the remaining embryos, 104 (69%, Table 1 ) did not exhibit any expression, and five (3%, Table 1 ) had only scattered spotty expression in a very small number of cells (not shown).
In contrast, when the reporter plasmid was injected without I-SceI, all the surviving embryos exhibited mosaic expression without any apparent tissue specificity ( Fig. 1I ; Table 1 ), as observed in simple plasmid injection experiments (Sargent and Mathers, 1991; Vize et al., 1991; Kroll and Amaya, 1996) . Similar mosaic expression was also observed in all the embryos when I-SceI was co-injected along with the construct that contains the same Pax6-GFP cassette but no I-SceI recognition site (Pax6GFP, Table 1 ), indicating that the combination of I-SceI and I-SceI recognition sites in the reporter construct is essential for promoter-dependent uniform expression. It is noteworthy that this combination not only stimulated promoter-dependent expression but also suppressed ectopic expression from the injected construct. These results indicate that the I-SceI-mediated transgenesis method works in X. tropicalis, presumably by stimulating integration of the injected construct into the host genome as in Medaka (Thermes et al., 2002) .
Optimization of transgenesis conditions in X. tropicalis and application to X. laevis
To further increase the efficiency of generating putative transgenics, we systematically changed the buffer concentration, DNA (IS-Pax6GFP) and enzyme amounts in the injection reaction mixture, and scored GFP expression in resulting embryos in tadpoles (stage 41). In the initial experiment described above, we set the concentration of I-SceI buffer in the reaction mixture to 0.5! as in the original Medaka report (Thermes et al., 2002) . However, the use of 1! concentration buffer significantly increased number of the full transgenics from 3 to 5%, and that of the half transgenics from 9 to 16%, while decreased dead and abnormal embryos from 16 to 10% of the total injected embryos (Table 1) .
In addition to the buffer concentration, DNA amount was very critical to improve efficiency. The number of full transgenics and that of half transgenics were increased to 10 and 21%, respectively, by injecting 80 pg instead of 40 pg of the DNA into one embryo using 1! buffer (Table 1 ). The sum of full and half transgenics reached more than 30% of injected embryos under these conditions. If the calculation is made based on normal survivors, then more than 40% were transgenics. Despite the increase of the DNA amount, the fraction of embryos with ectopic expression was still very small (2%). Even when the expression was scored at earlier stages (gastrula and neurula stages) when the embryos might still retain considerable amounts of the 'unintegrated' constructs, the fraction of embryos with ectopic expression was as small as that scored at the tadpole stages (2-3%). Further increase of injected DNA level led to a significant increase in dead and abnormal embryos (71% with 160 pg of DNA, Table 1 ) and a decrease in the fraction of healthy transgenic embryos, indicating that approximately 80 pg is the optimum amount of DNA for injection. The effect of increasing the level of I-SceI enzyme from 1 to 4!10 K3 U per embryo was tested with 120 pg of the DNA and 1! buffer, and it was found that this decreased the fraction of dead and abnormal embryos from 46 to 13%, but also slightly decreased the fraction of transgenic embryos.
Based on the conditions optimized in X. tropicalis, we also applied this technique to X. laevis to test its potential in this species. We injected reaction mixture containing 80 pg of ISPax6GFP plasmid, 1!10 K3 U I-SceI, and 1! buffer into fertilized X. laevis eggs. Three percent of injected embryos exhibited the Pax6 promoter-specific expression identical with that observed in X. tropicalis in both sides of their bodies, and 9% exhibited the half transgenic expression (nZ178). We also injected 240 pg of IS-Pax6GFP plasmid together with 3! 10 K3 U I-SceI, to compensate for larger volume of X. laevis eggs. In this case, 12 and 9% were full and half transgenics, respectively (nZ109).
Generation of transgenic X. tropicalis carrying other tissue-specific and ubiquitous promoter constructs using I-SceI meganuclease
The I-SceI-mediated transgenesis was performed with different reporter constructs to test further its potential. To examine another tissue-specific promoter, we chose to use a plasmid carrying the muscle-specific a-actin promoter of zebrafish (pa-actGFPI2), which was originally used to develop I-SceI method in fish (Thermes et al., 2002) . This plasmid has a promoter-GFP cassette flanked by two I-SceI recognition sites as the IS-Pax6GFP. Embryos injected with pa-actGFPI2 exhibited muscle-specific GFP expression ( Fig. 2A) . Some of the embryos had additional spotty expression in a few scattered cells ( Fig. 2A inset, arrowhead) , but the rest of the expression in muscle was uniform. As in the case of the IS-Pax6GFP injection, the injection of pa-actGFPI2 also generated 'full' and 'half transgenics', whose ratios were similar to the ratios observed with the same amount of the Pax6 reporter (Table 1) .
To examine very broadly expressed promoter constructs, we generated two GFP reporter plasmids carrying different promoters; one has the Xenopus EF-1a promoter (ISXeXGFP) and another one has the simian CMV IE94 promoter (IS-CSGFP). These plasmids also contain the promoter-GFP cassette flanked by two I-SceI recognition sites. Embryos injected with IS-XeXGFP exhibited uniform ubiquitous GFP expression beginning at neural plate stages (not shown). In addition to the uniform expression, spotty expression was also observed in some embryos in several cells at tailbud stages (Fig. 2B, arrowhead) . This spotty expression almost completely disappeared by swimming tadpole stages, whereas the uniform expression remained through the whole body (Fig. 2C ). Similar GFP expression was observed in embryos injected with IS-CSGFP (Fig. 2D ).
Germline transmission of transgenes co-injected with I-SceI
The founder embryos expressing GFP under the control of Pax6 or a-actin promoter were raised to sexual maturity. Some of them were then mated to wild-type animals, and GFP expression in their offspring was scored at tadpole stages to estimate germline transmission rate of the transgenes.
For the Pax6 construct, we tested two founder animals (ISPax6GFP #1 and IS-Pax6GFP #2, Table 2 ). In case of the #1 founder, GFP expression was observed in 26% of its offspring (Table 2 ). This germline transmission rate, 26%, is near the expected Mendelian ratio for a transgene integrated at a single locus, considering the fact that the founder #1 was 'half transgenic'. This founder exhibited promoter-dependent expression only in one side of the body, while its offspring had the expression in both sides (Fig. 3A) . The founder #2 also appeared to be a half transgenic, but only 17% of its offspring expressed GFP.
For the a-actin construct, we tested five founder animals (pa-actGFPI2 #1-#5, Table 2 ). The #4 founder was a full transgenic, and its germline transmission rate, 47%, is near the expected Mendelian ratio. The #1 and #2 founders were half transgenics and their germline transmission rates, 25 and 27%, respectively, are consistent with their expression. In case of the #5 founder, more than 50% of its offspring exhibited GFP expression, indicating that multiple transgene insertions into different chromosomes occured in its germline. This suggests that segregation of multiple different insertions at F2 generation is required in some cases to generate clonal transgenic populations. In case of the #3, only 17% of its offspring exhibited GFP expression. The pa-actGFPI2 offspring from all of these founder animals had expression in both sides of their body as was seen with the IS-Pax6GFP offspring (Fig. 3B) , and the spotty expression observed infrequently in founder animals ( Fig. 2A inset, arrowhead) was never seen in these animals.
The 17% germline transmission rate suggests that the founders might be 'quarter transgenics' in which the transgene integration happened at the four-cell stage, or the transgene integration might happen more than once at later than the four-cell stage. It was very difficult to distinguish half and quarter transgenics in the Pax6 construct-injected Table 2 ) were digested with BamHI, and hybridized with the XhoI-EcoRV fragment excised from paactGFPI2 plasmid (D). Wt; genomic DNA from a wild-type tadpole. 1a-d; genomic DNAs from four F1 tadpoles generated from the #1 founder. 3a-d; genomic DNAs from four F1 tadpoles generated from the #3 founder. 1!-6!; plasmid standards (pa-actGFPI2 plasmid digested with BamHI). Quantities indicated at the top of each lane correspond to one to six copies plasmid integrated in the genome. (D) Hypothesized schematic representation of the integrated transgenes in the pa-actGFPI2 #1 transgenic line. The structure was suggested based on the result of the Southern blot analysis shown in C. Two inverted copies of the transgene integrated at a single locus are indicated as Insert-1 and Insert-2. The length offragments resulting from BamHI digestion is indicated as 2.5, 2.0, 4.9, 1.9, 2.0, and 1.0 (kb). The green and light red boxes represent a GFP-poly(A) cassette and zebrafish. a-actin promoter, respectively. A pair of blue boxes represents an I-SceI site that consists of a long and short half site, reflecting the asymmetry of cutting by this enzyme (Jacquier and Dujon, 1985) . A black broken line and a gray line represent the flanking genomic DNA and the plasmid backbone, respectively. The 4.9 kb BamHI fragment includes a 1.9 kb region from the a-actin promoter and the 3.0-kb plasmid backbone.
embryos. This is because the Pax6 promoter restricts the GFP expression mostly in the central nervous tissues (Fig. 1D) , which are primarily derived from dorsal blastomeres formed at the four-cell stage. Expression of the transgene integrated in one of the dorsal blastomeres at the four-cell stage would be almost identical with expression of the transgene integrated in one of the blastomeres at the two-cell stage. Despite the generation of half or quarter transgenics, I-SceI reaction mixtures had to be injected at the one-cell stage, since embryos injected at the two-cell stage did not exhibit the promoterdependent expression (not shown). An alternative hypothesis to explain these numbers is simply that there is not an exactly equal number of germ cell products derived from each half of the half-transgenic embryos.
The nature of transgene integrations in F1 animals was analyzed by Southern blot hybridization. Genomic DNA was extracted from an F1 tadpole of the pa-actGFPI2 #1 founder (1a) and an F1 tadpole from the pa-actGFPI2 #3 founder (3a), and digested with BamHI, which cuts the pa-actGFPI2 plasmid into three large fragments (Fig. 3D) . The blot was hybridized with a probe to the whole promoter-GFP cassette excised from pa-actGFPI2 (Fig. 3D) . The patterns of bands observed here were very similar to that of the transgenic fish generated by the I-SceI method (Thermes et al., 2002) . The entire plasmid was inserted in both 1a and 3a tadpoles, as demonstrated by the presence of the expected fragments (1.0, 2.0, and 4.9 kb, Fig. 3C, left panel) . The copy number of each fragment was estimated by comparing its signal intensity with that of a standard array of the digested plasmid DNA (Fig. 3C , left panel, Plasmid standards). In case of tadpole 1a, the copy number of the 4.9, 2.0, and 1.0-kb fragments is estimated to be one, three, and one, respectively. The presence of one copy of the 4.9 and 1.0-kb fragment suggests the insertion of two copies of the entire plasmid at a single locus (Fig. 3D , Insert-1 and Insert-2). These two plasmids appear to be linearized by digestion at either one of the two I-SceI sites, respectively, when they were integrated into the host genome. The band that appears to be about 2.0 kb may contain two copies of the 2.0 kb fragment and one copy of the 1.9-kb fragment, which is consistent with the hypothesis that these two plasmids are in inverted orientation. The 2.5-kb fragment likely consists of the 1.0 kb GFP-poly(A) cassette and 1.5 kb of flanking genomic DNA. In case of the 3a tadpole, it is not straightforward to model the structure of integrated transgenes, but the signal intensity of the 1.0 kb band suggests insertion of four, or possibly a few more, copies of the entire plasmid (Fig. 3C, left  panel) .
Since the germline transmission test (Table 2) implied that multiple independent transgene integrations might occur in the germline of some founder animals, we analyzed three more F1 tadpoles from the pa-actGFPI2 #1 founder by Southern blot hybridization (Fig. 3C, right panel, 1b-d) . These three individuals showed a pattern of bands identical with that of the 1a tadpole. Three more F1 tadpoles from the pa-actGFPI2 #3 founder were also analyzed in the same way, and also showed a pattern identical with the 3a tadpole (Fig. 3C, right  panel, 3b, 3c, and 3d) . Thus, in case of the two founder animals tested here, transgene integrations in the germline appear to be non-mosaic and multiple integrations into different chromosomes do not appear to be a frequent occurrence.
The relatively small copy number of integrated transgenes observed here is consistent with the data shown in the previous report (Thermes et al., 2002) . This feature may efficiently avoid gene-silencing, a problem often encountered in transgenic animals (Garrick et al., 1998) and also possibly in the REMI transgenesis which introduces a much larger copy number of transgenes (up to 35 copies, (Kroll and Amaya, 1996) ). In the pa-actGFPI2 founder animals, some fraction exhibited weaker expression than the F1 tadpoles from the pa-actGFPI2 #1 founder carrying two copies of the transgene (not shown), implying even single copy insertion is possibly generated by the I-SceI method.
This Southern blot analysis showed incorporation of the vector sequence along with the transgene cassette, as observed in the previous fish report (Thermes et al., 2002) . Though it is not known if this is an obligatory feature of the method, it might be important to carefully choose vectors for transgene construction, because some vector sequences lead to strong background expression in transgenic Xenopus (Hirsch et al., 2002b) .
In vivo analysis of promoter-transcription factor interaction by combination of I-SceI transgenesis and mRNA injection
It is quite challenging to combine the REMI transgenesis and injection of other molecules such as mRNAs or morpholino antisense oligonucleotides, since eggs transplanted with sperm nuclei are fragile and do not tolerate subsequent injection experiments (N. Hirsch and R. Grainger, unpublished) and the buffer used for REMI transgenesis, because of the presence of spermidine and spermine, is not compatible with co-injection of nucleic acids. However, the I-SceI method employs a standard microinjection procedure which does not damage embryos significantly, and is expected to be compatible with other injection experiments. To test this possibility, we designed a sequential injection experiment with an mRNA encoding a transcription factor and a reporter plasmid carrying its target promoter element. As a transcription factor, we chose to employ L-Maf, a member of Maf family proteins expressed exclusively in the developing lens (Ogino and Yasuda, 1998) . L-Maf was originally discovered as a factor that binds to the regulatory motif conserved in lens-specific crystallin genes, and misexpression of L-Maf induces ectopic expression of crystallins in chicken and Xenopus embryos (Ogino and Yasuda, 1998; Ishibashi and Yasuda, 2001; Hirsch and Grainger, unpublished) . As a reporter plasmid, we used ISg-cryVenus, which carries K800 bp promoter region of Xenopus g1-crystallin gene fused with Venus (a GFP variant modified for rapid maturation, (Nagai et al., 2002) ) and two flanking I-SceI sites. The tightly regulated lens-specific activity of the g1-crystallin promoter, which contains two putative binding motifs of Maf proteins (Ogino and Yasuda, 2000) , has been well characterized in transgenic Xenopus studies (Offield et al., 2000) .
IS-g-cryVenus was first injected into one-cell stage embryos along with I-SceI, and subsequently, either chicken L-maf or lacZ mRNA was injected at the eight-cell stage. The mRNA injection was localized to animal blastomeres (50 pg per blastomere, total 200 pg per embryo), to circumvent gastrulation defects which are otherwise seen when L-maf mRNA is expressed in vegetal cells that give rise to dorsal mesoderm. The injected embryos were raised to stage 41 and examined for reporter expression. In the L-maf-injected embryos, expression was observed not only in the lens (arrow in Fig. 4A ) but also broadly in the brain, spinal cord, and in some parts of the facial skin (arrowheads in Fig. 4A , nZ 14/14), while expresion in the lacZ-injected embryos was tightly restricted in the lens (Fig. 4B , nZ17/17) as seen in the embryos not injected with the mRNAs (not shown, nZ45/45). The lens of the L-maf-injected embryos appeared to be somewhat abnormal as reported previously (Ishibashi and Yasuda, 2001) , and exhibited weaker expression than the lenses of lacZ-injected embryos. The expression pattern of the reporter gene observed in the L-maf-injected embryos is consistent with that of ectopic expression of endogenous g1-crystallin gene induced by L-maf misexpression (Ishibashi and Yasuda, 2001; Hirsch and Grainger, unpublished) . We also injected IS-g-cryVenus and L-maf mRNA without I-SceI, which resulted in only weak spotty expression distributed through the whole body (nZ12/14, not shown). This result is consistent with other experiments in our laboratory suggesting that there must be factors that restrict ectopic crystallin expression to anterior ectoderm when L-maf is injected (N. Hirsch and R. Grainger, unpublished) . Such co-injection assays could clearly be used to map key enhancer elements regulating the specific response seen here. We have also shown that this transgenesis procedure is compatible with co-injection with morpholino antisense oligonucleotides (data not shown).
Discussion
In this study, we successfully adapted the I-SceI meganuclease-mediated transgenesis technique to X. tropicalis and also to X. laevis. The advantages of I-SceI transgenesis over REMI transgenesis are its ease, little damage to the injected embryos, very high efficiency, and relatively low copy number of integrated transgenes. Because of these advantages, the I-SceI technique will make it possible to quickly perform more refined experiments using founder embryos, which include enhancer/promoter analysis, gene interaction analysis by combination of transgenesis with mRNA or morpholino antisense oligonucleotide injection, and targeted misexpression. Moreover, because of the procedure works so well in X. tropicalis, this method will be also very useful for multigenerational studies including approaches like enhancer or gene trap experiments. These possibilities are further discussed below.
3.1. High-throughput assays using founder transgenic animals generated by the I-SceI method
The I-SceI method has the prospect of adding a new dimension to enhancer/promoter analyses. Development of a high-throughput system for survey of cis-regulatory elements in vertebrate genomes is an absolute requirement for the post-genomic era (Venkatesh and Yap, 2005) . Recent remarkable progress of comparative analysis of genome sequences has revealed a large number of highly conserved non-coding regions (HCNRs) distributed throughout vertebrate genomes (Bejerano et al., 2004; Wasserman and Sandelin, 2004) . Functional characterization of HCNRs has started recently, which suggested that many of them are regulatory elements associated with development ( initial studies were performed by electroporation of plasmid DNA into chicken embryos, direct DNA injection into zebrafish embryos, or by REMI transgenesis in Xenopus. However, the expression in chicken embryos is transient and from extrachromosomally retained plasmid DNA (Muramatsu et al., 1997; Momose et al., 1999) , the expression in zebrafish is very mosaic (Westerfield et al., 1992) , and the REMI method is too laborious for a high-throughput analysis. The I-SceI method in X. tropicalis is much more suitable than these assays for rapidly building up annotations of the HCNRs. Owing to the short generation time of X. tropicalis, systematic analysis of HCNRs by the I-SceI transgenesis will simultaneously lead to the generation of a variety of transgenic lines, which will be very useful resources for developmental biology studies.
Combination of the I-SceI transgenesis with mRNA or morpholino antisense oligonucleotide injection would be very useful for analysis of interactions of transcription factors with the HCNRs. Up to now, for analysis of interactions between cis-regulatory elements and transcription factors, most vertebrate studies have used transient assays, such as co-transfection assays in cultured mammalian or avian cells, or simple co-injection of reporter plasmids carrying cis-elements along with mRNAs encoding transcription factors into Xenopus embryos. These assays are not ideal, since the cell cultures may not reflect the complexities of a more complete developmental context, and the directly injected DNA, most of which remains extrachromosomal (Etkin and Pearman, 1987) , may not faithfully reflect chromosomal context. In contrast to these assays, the combination of the I-SceI transgenesis with mRNA injection quickly tests interactions of transcription factors with cis-elements in the chromosomal context of developing embryos. Morpholino antisense oligonucleotides should be a useful tool for knockdown experiments in X. tropicalis performed in conjunction with examination of cisregulation of transgenes. Morpholinos act very efficiently in X. tropicalis due to its diploid genome and the availability of a large full-length cDNA database (Gilchrist et al., 2004; Kenwrick et al., 2004; Khokha et al., 2005) , as well as the availability of highly inbred lines that mitigate problems with sequence variation in target sequences (Hirsch et al., 2002a) .
For targeted misexpression studies, the REMI transgenesis technique is not ideal (Chae et al., 2002; Hartley et al., 2002) . This is primarily because the REMI method itself induces abnormal development at high frequency (only 5-40% of cleaving eggs develop normally; (Kroll and Amaya, 1996) ), which often hinders interpretation of the phenotype associated with misexpressed genes. A binary GAL4-UAS system was introduced to overcome this problem (Chae et al., 2002; Hartley et al., 2002) . However, it in turn involves a timeconsuming step, the generation of activator transgenic lines expressing GAL4 and effector lines carrying the gene of interest linked with the UAS sequences. In the I-SceI transgenesis, more than 70% of injected embryos develop normally at optimized conditions, and more than 40% of these normally developing embryos are transgenics (Table 1) . These results suggest that the I-SceI method will be quite useful for performing misexpression experiments in founder animals with little concern because of abnormality induced by the transgenesis procedure itself.
Furthermore, the half transgenics generated by the I-SceI method have a significant advantage for misexpression studies. In examining the effect of expression of a transgenic construct the non-transgenic side offers a control to monitor possible abnormalities induced by the transgenesis procedure itself. For this kind of experiment, transgene constructs carrying two expression cassettes may be useful (Chae et al., 2002) . One cassette can be used as a reporter to identify the transgenic side, and another one for misexpression of a gene of interest. In experiments in which an mRNA is injected along with a transgenic construct, the half-transgenics may also serve as a control to compare the biological effect of the RNA on transgenic and non-transgenic sides of the embryo.
Use of the I-SceI transgenesis technique for insertional mutagenesis in Xenopus
X. tropicalis was introduced to promote genetic studies in Xenopus. To date, several naturally occurring mutations have been identified Noramly et al., 2005) , and chemical and g-ray mutagenesis projects are ongoing in our lab and others (L. Zimmerman and R. M. Harland, personal communications). However, a more straightforward mutagenesis strategy that quickly links mutant phenotype with the mutated gene is insertional mutagenesis. Our lab and others have attempted to do insertional mutagenesis in X. tropicalis using the REMI method, retroviral vectors, or transposons, all of which has resulted in very limited success (T. Nakayama, J. Chae, and R. M. Grainger, unpublished observations; E. Amaya, personal communication) . In contrast, the I-SceI method developed in this study is far more efficient, allowing the production of thousands of transgenic embryos, as required for an efficient implementation of this strategy. The original report of I-SceI transgenesis in fish also showed preliminary enhancer trap data (Thermes et al., 2002) . Therefore we have performed pilot experiments using an I-SceI-mediated gene trap vector modified from the GFP trap vector that was originally used for a REMI transgenesis gene trap screen in X. laevis (Bronchain et al., 1999) . Most of the injected embryos did not exhibit GFP expression, but some did show restricted GFP expression in particular tissues (W. McConnell, T. Nakayama, H. Ogino and R. Grainger, unpublished observations) . This data supports the feasibility of I-SceI-mediated trapping experiments in X. tropicalis.
Using this technique, even a lab that has no experience in Xenopus transgenesis can start making transgenic X. tropicalis immediately, which will in turn result in enrichment of Xenopus genetic resources in the field of developmental biology.
Methods
Plasmid constructs
Pax6GFP was provided by Dr E. Amaya (Hartley et al., 2001 ). The ISPax6GFP was generated by introducing the Pax6 promoter-GFP-poly(A) cassette excised from Pax6GFP into a modified pBluescriptII SKCcarrying I-SceI sites in both ends of its polylinker (ISceI-pBSII SKC; a gift from Dr J. Wittbrodt, (Thermes et al., 2002) ). The pa-actGFPI2 was obtained from Drs V. Thermes and J. -S. Joly (Thermes et al., 2002) . IS-CSGFP was generated from pCS2CEGFP, which was made by introducing the EGFP coding sequence excised from pEGFP-1 (Clontech, USA) 3 0 to the simian CMV IE94 promoter of pCS2C (Rupp et al., 1994) . The CMV promoter-GFP-poly(A) cassette excised from the pCS2CEGFP was introduced into the polylinker of the ISceIpBSII SKC to generate IS-CSGFP. IS-XeXGFP was made by replacing the CMV promoter of IS-CSGFP with the Xenopus EF-1a promoter excised from pXeX (Johnson and Krieg, 1994) . IS-g-cryVenus (constructed by T. Nakayama) was made by introducing an 800 bp Xenopus g1-crystallin promoter excised from 800g1-crys/GFP3 (Offield et al., 2000) and the Venus-poly(A) cassette excised from pCS2CVenus (a gift from Dr A. Miyawaki, (Nagai et al., 2002) ) into ISceI-pBSII SKC. The plasmid carrying chicken L-maf cDNA, pEFX-L-Maf, was described previously (Ogino and Yasuda, 1998) . pCS2Cb-gal was constructed by introducing the bgalactosidase coding sequence excised from pEFX-b-gal (Ogino and Yasuda, 1998) into pCS2C.
4.2. I-SceI-mediated transgenesis and subsequent RNA injection X. tropicalis females were primed about 20 h prior to egg laying with 15 units of human chorionic gonadotropin (HCG; Intervet, Holland). These females were then boosted with 100 units of HCG approximately 4 h prior to the egg laying. Eggs were squeezed from an individual female into a Petri dish containing 750 ml of homogenized testis suspended in 1!MBS containing 0.1% BSA. The eggs were incubated for 2 min at room temperature, after which the dish was flooded with 0.1!MBS and incubated for more about 10 min until the contraction of pigmented animal cap occurred. The eggs were then dejellyed with 0.1!MBS containing 2% cysteine (pH 8.0), and transferred into injection medium (6% Ficoll 400 in 0.1!MBS).
Plasmid DNAs used for the I-SceI transgenesis were purified using a Qiagen Maxiprep kit (Qiagen, USA). The plasmid (400-1600 ng) was incubated for 40 min at 37 8C in 20 ml of reaction mixture containing I-SceI (10 or 40 units, New England Biolabs, USA) and I-SceI buffer (0.5 or 1!, New England Biolabs, USA). Two nl of this reaction mixture was injected into one-cell embryos near the animal pole. To get a satisfactory percentage of transgenic embryos from a given batch of eggs, all injections were completed within 45 min after fertilization. The injected eggs were incubated at 22 8C in the injection medium until they reached the two-or four-cell stage, then transferred into 0.1!MBS and further incubated at 22-25 8C.
Regarding the incubation time of the I-SceI reaction at 37 8C, we tested 20, 40, and 80 min. The number of transgenics generated with the 20 or 80 min reaction was less than half of that with the 40 min reaction, and ectopic expression was especially evident with the 20 min reaction. A portion of these reaction mixtures was analyzed by agarose gel electrophoresis, which showed that the 20 min incubation was not sufficient for complete digestion of plasmid DNA. It is possible that the 80 min incubation might be too long to retain the enzyme activity in the reaction that appears essential for transgene integration in embryos.
The one-cell stage of X. tropicalis embryos lasts only 70 min at 22 8C. After the eggs are mixed with the homogenized testis, it takes for about 20 min for the pigment contraction, dejellying, and placing eggs in the injection medium. Thus, the remaining time window for the injection is only 50 min. We found injections during the early half of this time window (i.e. until 45 min after the fertilization), accounted for the number of transgenics shown in Table 1 ; additional injections during the second half of the first cell cycle did not significantly increase this number.
We tested keeping injected embryos at lower temperatures (16, 18, and 20 8C) until 2-4 cell stages, because we thought this might allow enough time for transgene integration prior to the first cleavage and increase the number of full transgenics. However, all of the embryos kept at 16 or 18 8C died before gastrulation stages. A small fraction of embryos kept at 20 8C (10-20%) reached gastrulation stages, but all of them failed to gastrulate properly. For X. laevis, however, incubation of the injected eggs at 13 8C until the 2-4 cell stage was very critical for increasing the transgenesis efficiency to a level comparable with that of X. tropicalis.
For RNA injection, chicken L-maf mRNA was generated from EcoRIlinearized pEFX-L-Maf transcribed with T7 RNA polymerase. lacZ mRNA was generated from NotI-linearized pCS2Cb-gal transcribed with SP6 RNA polymerase. The embryos injected with I-SceI reaction mixture were kept in the injection buffer and again injected with these mRNAs at the eight-cell stage. Two hundred pg of either L-maf or lacZ mRNA was injected into all animal blastomeres (50 pg per blastomere). After the injection, these embryos were transferred into 0.1!MBS and further incubated at 22-25 8C.
Epifluorescence microscopy and in situ hybridization
GFP fluorescence in embryos was observed using a Zeiss Stemi SV-11 microscope with fluorescent illumination and 470 nm GFP filter set. Photos were taken with a Zeiss AxioCam Mrc5 CCD camera assembled on the microscope.
Whole-mount in situ hybridization was performed as described previously (Sive et al., 2000) using a digoxygenin-labeled GFP probe, which was generated from BglII-linearized IS-Pax6GFP transcribed with T3 RNA polymerase. The stained embryos were bleached for better visualization of staining as described previously (Sive et al., 2000) .
Southern blot analysis
F1 embryos resulting from outcrossing of two pa-actGFPI2 founder animals with wild type animals were raised to late tadpole stages (stage 53-57). Genomic DNA was extracted from their tails using a DNeasy Tissue Kit (Qiagen, USA). Ten mg of DNA extracted from individual tadpoles was digested with BamHI, which cuts pa-actGFPI2 into four fragments (the smallest of which is too small to detect in this assay). DNA standards were prepared by digesting different amounts of pa-actGFPI2 with BamHI. Since the estimated genome size of X. tropicalis is 1.7!10 9 bp per haploid nucleus (Tymowska, 1973) , 47 pg of the digested pa-actGFPI2 was loaded to estimate the signal intensity of a single copy insertion in 10 mg of genomic DNA. Samples were separated on a 0.7% agarose gel in 0.5!TBE and blotted to a nylon membrane by capillary transfer. For probe preparation, the whole promoter-GFP cassette was excised from pa-actGFPI2 by XhoI and EcoRV digestion, and then labeled with [a-32 P]-dCTP using Random Primers DNA labeling System (Invitrogen, USA). The blotted filter was hybridized with this probe, and exposed to X-ray film.
